EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

GADD45β ‐ MTK1 signaling axis mediates oncogenic stress‐induced activation of the p38 and JNK pathways

Saeko Kawataki iD, Yuji Kubota, Kotoe Katayama, Seiya Imoto, Mutsuhiro Takekawa iD

Cancer Science · 2025-01 · 116 (1) · 128-142

DOI: 10.1111/cas.16389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 11.11.2024. Verfasst von Saeko Kawataki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cell Signaling and Molecular Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Early Growth Response Protein 1, p38 Mitogen-Activated Protein Kinases, MAP Kinase Signaling System. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Core Research for Evolutional Science and Technology, Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ERK pathway governs essential biological processes such as cell proliferation and survival, and its hyperactivation by various oncogenes ultimately drives carcinogenesis. However, normal mammalian cells typically recognize aberrant ERK signaling as oncogenic stress and respond by inducing cell cycle arrest or apoptosis through activation of the p38 and JNK pathways. Despite the critical role of this response in preventing carcinogenesis, the precise molecular mechanisms underlying oncogene‐induced, ERK‐dependent activation of p38/JNK and its tumor‐suppressive effects remain unclear. Here, we demonstrate that MAP three kinase 1 (MTK1), a stress‐responsive MAPKKK, serves as a key mediator of p38/JNK activation induced by oncogenic ERK signaling. Mechanistically, aberrant ERK signaling induces sustained expression of the transcription factor early growth response protein 1 (EGR1), which promotes the production of the MTK1 activator GADD45β, leading to persistent activation of MTK1‐p38/JNK signaling. Gene knockout and transcriptome analyses revealed that this GADD45β/MTK1‐mediated cross‐talk between the ERK and p38/JNK pathways preferentially upregulates a specific set of genes involved in apoptosis and the immune response. Notably, the expression of EGR1, GADD45β, and MTK1 is frequently downregulated in many cancers with high ERK activity, resulting in the disruption of the tumor‐suppressive ERK‐p38/JNK cross‐talk. Restoring GADD45β expression in cancer cells reactivates p38/JNK signaling and suppresses tumorigenesis. Our findings delineate a molecular mechanism by which normal cells sense and respond to oncogenic stress to prevent abnormal growth, and highlight the significance of its dysregulation in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Growth Response Protein 1p38 Mitogen-Activated Protein KinasesMAP Kinase Signaling SystemHumansAnimalsMiceApoptosisCell Line, TumorAntigens, DifferentiationSignal TransductionCell ProliferationGADD45 Proteins

Stichwörter der Autor:innen

ERKJNKoncogeneoncogenic stressp38

Substanzen

Early Growth Response Protein 1p38 Mitogen-Activated Protein KinasesAntigens, DifferentiationEGR1 protein, humanGADD45B protein, humanGADD45 Proteins

Autor:innen und Institutionen

  • Division of Cell Signaling and Molecular Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.
  • Laboratory of Sequence Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Division of Health Medical Intelligence, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Saeko Kawataki, Mutsuhiro Takekawa

Förderung

  • Core Research for Evolutional Science and Technology
  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development

Zitieren

APA

Kawataki, S., Kubota, Y., Katayama, K., Imoto, S., & Takekawa, M. (2025). GADD45β ‐ MTK1 signaling axis mediates oncogenic stress‐induced activation of the p38 and JNK pathways. Cancer Science, 116(1), 128-142. https://doi.org/10.1111/cas.16389

Vancouver

Kawataki S, Kubota Y, Katayama K, Imoto S, Takekawa M. GADD45β ‐ MTK1 signaling axis mediates oncogenic stress‐induced activation of the p38 and JNK pathways. Cancer Science. 2025;116(1):128-142. doi:10.1111/cas.16389

BibTeX
@article{Kawataki2025,
  author = {Kawataki, Saeko and Kubota, Yuji and Katayama, Kotoe and Imoto, Seiya and Takekawa, Mutsuhiro},
  title = {GADD45β ‐ MTK1 signaling axis mediates oncogenic stress‐induced activation of the p38 and JNK pathways},
  journal = {Cancer Science},
  year = {2025},
  volume = {116},
  number = {1},
  pages = {128--142},
  doi = {10.1111/cas.16389}
}
Kostenlos starten →